Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-01-08 00:00:00 ET · period of report 2024-01-04 · accession 0000950170-24-003177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-08 | 2024-01-04 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $0.82 | -4,114 | 783.5K | -0.5% | -$3,373 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | S | D | 4,114 | $0.82 | 783,465 | D | — | — |